Tovorafenib Impurity 41 | CAS 1446111-08-5 - Request Quote
Tovorafenib Impurity 41
| SZ CAT No: | SZ-T202049 |
| CAS No | 1446111-08-5 |
| Mol.F. | C5H4ClN3O2 |
| Mol.Wt. | 173.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tovorafenib Impurity 41 is chemically 4-Amino-6-chloropyrimidine-5-carboxylic acid. Tovorafenib Impurity 41 is supplied with detailed characterization data compliant with regulatory guideline. Tovorafenib Impurity 41 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tovorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1446111-08-5
Purchase 1446111-08-5
Order 1446111-08-5
Enquire 1446111-08-5
price of 1446111-08-5
1446111-08-5 Supplier
1446111-08-5 Manufacturer
1446111-08-5 Exporter
buy high quality Tovorafenib Impurity 41
Purchase Tovorafenib Impurity 41
Tovorafenib Impurity 41 suppliers
Tovorafenib Impurity 41 manufacturers
Tovorafenib Impurity 41 price
Order Tovorafenib Impurity 41
Enquire Tovorafenib Impurity 41
Tovorafenib Impurity 41 cost
Tovorafenib Impurity 41 Supplier
Tovorafenib Impurity 41 Distributor
Tovorafenib Impurity 41 for Method Validation
Tovorafenib Reference Standard
Tovorafenib Impurity 41 for ANDA Filing
Tovorafenib Impurity 41 for Forced Degradation Studies
Tovorafenib Impurity 41 Identification Standards
Tovorafenib Impurity 41 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


